Die Statintherapie gilt als einer der größten Fortschritte in der Prävention atherosklerotisch bedingter kardiovaskulärer Ereignisse. Doch trotz Statingabe erreichen viele Patienten nicht ihre Ziel-LDL-Werte. Bempedoic Acid (kurz BA) könnte für diese Patienten ein potenter Kombinationspartner zur Statintherapie sein. Doch wie sieht die Studienlage aus - vor ... Show More
Jul 2021
Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
Several new therapeutic drug classes are now available to manage lipid levels. John Wilkins, MD, MS, and Donald Lloyd-Jones, MD, ScM, of the Department of Preventive Medicine and Division of Cardiology at Northwestern University Feinberg School of Medicine, discuss the use of eze ... Show More
35m 24s
Sep 2021
143. Lipids: (Non)-Fasting LDL & Furious Lipid Lowering with Dr. Alison Bailey
CardioNerds Dr. Rick Ferraro, Director of the #CardsJC Journal Club and cardiology fellow at Johns Hopkins, and Dr. Tommy Das, Program Director of the CardioNerds Academy and cardiology fellow at Cleveland Clinic, learn all about the clinical application of the ASCVD primary and ... Show More
35m 49s
Jun 2024
#525: Cholesterol-Lowering Medication – Dr. Paddy Barrett
<p>Cholesterol-lowering medications, particularly statins, play a pivotal role in reducing low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) concentrations, which are causal markers in atherosclerosis development. The efficacy of these medications is well-do ... Show More
48m 29s
May 2023
Non-Statins for LDL Lowering
Special guest Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University joi ... Show More
32m 58s